Purpose
The aim was to compare the surgical results, patient satisfaction, and esthetic outcome of anterior lamellar recession (ALR) with and without blepharoplasty in the treatment of upper eyelid cicatricial entropion.
Patients and methods
This study included 44 eyelids of 30 patients allocated randomly into two groups. Group A: 22 eyelids underwent an ALR surgery. Group B: 22 eyelids underwent an ALR with blepharoplasty. The main outcomes are surgical results, patient satisfaction, and esthetic outcome.
Results
At the end of 6-month follow-up, the success rate of group A was 81.8% (72.7% had complete success, while 9.1% had partial success), and failure was encountered in 18.2%, while it was 100% (95.5% had complete success, while 4.5% had partial success), with no failure reported in group B. The esthetic outcome was fair in 31.8% and poor in 68.2% in group A, while it was good in 77.3% and fair in 22.7% in group B, with a highly significant statistical difference between the two groups (P=0.001*). Patient satisfaction was 72.7% (45.5% were satisfied, while 27.3% were partially satisfied) and 27.3% were dissatisfied in group A, while it was 95.4% (90.9% were satisfied, while 4.5% were partially satisfied) and 4.5% were dissatisfied in group B, with a highly significant statistical difference between the two groups (P=0.005*).
Conclusion
In the surgical repair of upper eyelid cicatricial entropion, ALR combined with blepharoplasty has a better functional and esthetic outcome and a greater success rate than ALR alone. It also aids in the treatment of related dermatochalasis, hence optimizing ALR efficacy and improving postoperative cosmesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.